title: Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis.
authors.affiliation: Vanderbilt University, Nashville, Tennessee.
authors.forename: David
authors.initials: D
authors.lastname: Afshartous
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Seth R
authors.initials: SR
authors.lastname: Bauer
authors.affiliation: Emory University, Atlanta, Georgia.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Connor
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Olufemi A
authors.initials: OA
authors.lastname: Aduroja
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Milen
authors.initials: M
authors.lastname: Amde
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Charbel
authors.initials: C
authors.lastname: Salem
authors.affiliation: Vanderbilt University, Nashville, Tennessee.
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Groszek
authors.affiliation: Vanderbilt University, Nashville, Tennessee. Electronic address: william.fissell@vanderbilt.edu.
authors.forename: William H
authors.initials: WH
authors.lastname: Fissell
mesh_terms: D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics; D016638:Critical Illness / Q000628:therapy*; D054796:Drug Dosage Calculations; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D015378:Imipenem / Q000493:pharmacokinetics*; D008297:Male; D008508:Medication Errors / Q000517:prevention & control; D000077731:Meropenem; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D013845:Thienamycins / Q000493:pharmacokinetics*
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D015378:Imipenem; D000077731:Meropenem